CND Life Sciences, Inc.
Amendment
CIK: 0001841099·Biotechnology·DELAWARE·Filed: Apr 15, 2025
Total Offering
$9,000,000
Amount Sold
$3,664,565
Investors
27
First Sale
Feb 28, 2025
Offering Details
- Type
- Equity
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| Richard J. Morello | Related Person |
| Todd Levine | Related Person |
| Peter Harris | Related Person |
| Enrique Carrazana | Related Person |
| Christopher Gibbons | Related Person |
| Jack Seaver | Related Person |
Company
SEC Filing
0001841099-25-000003
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free